Please try another search
For the nine months ended 30 September 2020,CorMedix Inc. revenues decreased 29% to $184K. Net lossapplicable to common stockholders decreased 58% to $15.9M.Revenues reflect a decrease in demand for the Company'sproducts and services due to unfavorable market conditions.Lower net loss reflects Interest Expenses decrease of 96%to $28K (expense). Basic Earnings per Share excludingExtraordinary Items increased from -$1.60 to -$0.58.
Period Ending: | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
---|---|---|---|---|
Total Revenue | 0.09 | 0.02 | 0.07 | 0.02 |
Gross Profit | 0.01 | -0 | 0.03 | -0.02 |
Operating Income | -6.6 | -8.92 | -5.61 | -5.38 |
Net Income | -6.6 | -3.78 | -5.56 | -5.3 |
Period Ending: | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
---|---|---|---|---|
Total Assets | 40.02 | 24.24 | 27.4 | 29.48 |
Total Liabilities | 5.55 | 5.72 | 5.81 | 5.83 |
Total Equity | 34.47 | 18.52 | 21.59 | 23.65 |
Period Ending: | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -16.03 | -8.72 | -7.97 | -15.05 |
Cash From Investing Activities | 9.27 | 6.03 | 0.99 | -12.02 |
Cash From Financing Activities | 24.78 | 2.83 | 2.83 | 25.8 |
Net Change in Cash | 18.02 | 0.14 | -4.15 | -1.27 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review